The genetics of deliria

International Review of Psychiatry

Volumn 21, Issue 1, 2009, Pages 20-29

  Adamis, Dimitrios ^a   Van Munster, Barbara C ^b   Macdonald, Alastair J D ^c  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR 3; DOPAMINE TRANSPORTER; GLUTAMIC ACID; SEROTONIN; UNCLASSIFIED DRUG;

CLINICAL EVALUATION; DELIRIUM TREMENS; DISEASE DURATION; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MEDICAL RESEARCH; METHODOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SOAT 1 GENE;

APOLIPOPROTEINS E; BRAIN; CATECHOL O-METHYLTRANSFERASE; DELIRIUM; FEMALE; GENOTYPE; GLUTAMIC ACID; HUMANS; MALE; POLYMORPHISM, GENETIC; SUBSTANCE-RELATED DISORDERS;

EID: 60749107238     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260802675510     Document Type: Review

References (75)

1. Adamis, D., & Macdonald, A. J. (2009). A review of the association of Apolipoprotein E and delirium. In Penfield, L. F., & Nelson, R. (Eds.), Apo Protein Research, Nova Science Publishers.
2. Adamis, D., Treloar, A., Martin, F. C., Gregson, N., Hamilton, G., & Macdonald, A. J. (2007). APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients. International Journal of Geriatric Psychiatry, 22(7), 688-694.
3. Adamis, D., Treloar, A., Martin, F. C., & Macdonald, A. J. D. (2006). Recovery and outcome of delirium in elderly medical inpatients. Archives of Gerontology and Geriatrics, 43(2), 289-298.
4. Arendt, T., Schindler, C., Bruckner, M. K., Eschrich, K., Bigl, V., Zedlick, D. et al. (1997). Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. Journal of Neuroscience, 17(2), 516-529.
5. Bayard, M., McIntyre, J., Hill, K. R., & Woodside Jr, J. (2004). Alcohol withdrawal syndrome. American Family Physician, 69(6), 1443-1450.
6. Beffert, U., Danik, M., Krzywkowski, P., Ramassamy, C., Berrada, F., & Poirier, J. (1998). The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Research and Brain Research Review, 27(2), 119-142.
7. Birkmayer, W. (1978). Toxic delirium after L-dopa medication. Journal of Neural Transmission Supplement, 14(supplement), 163-166.
8. Cruz, C., Camarena, B., Mejia, J. M., Paez, F., Eroza, V., Ramon De La Fuente, J. et al. (1995). The dopamine D2 receptor gene TaqI A1 polymorphism and alcoholism in a Mexican population. Archives of Medical Research, 26(4), 421-426.
9. Cummings, J. L. (1991). Behavioral complications of drug treatment of Parkinson's disease. Journal of the American Geriatrics Society, 39(7), 708-716.
10. DeBellis, R., Smith, B. S., Choi, S., & Malloy, M. (2005). Management of delirium tremens. Journal of Intensive Care Medicine, 20(3), 164-173.
11. Ely, E. W., Girard, T. D., Shintani, A. K., Jackson, J. C., Gordon, S. M., Thomason, J. W. W. et al. (2007). Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Critical Care Medicine, 35(1), 112-117.
12. Flacker, J. M., & Lipsitz, L. A. (1999). Neural mechanisms of delirium: Current hypotheses and evolving concepts. Journal of Gerontology A Biological Sciences and Medical Sciences, 54(6), 239-246.
13. Fulton, M. K., Kramer, G., Moeller, F. G., Chae, Y., Isbell, P. G., & Petty, F. (1995). Low plasma homovanillic acid levels in recently abstinent alcoholic men. American Journal of Psychiatry, 152(12), 1819-1820.
14. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379(6566), 606-612.
15. Gora-Maslak, G., McClearn, G. E., Crabbe, J. C., Phillips, T. J., Belknap, J. K., & Plomin, R. (1991). Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology. Psychopharmacology (Berlin), 104(4), 413-424.
16. Gorwood, P., Limosin, F., Batel, P., Hamon, M., Ades, J., & Boni, C. (2003). The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biological Psychiatry, 53(1), 85-92.
17. Harris, G. C., & Aston-Jones, G. (1994). Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature, 371(6493), 155-157.
18. Hersh, D., Kranzler, H. R., & Meyer, R. E. (1997). Persistent delirium following cessation of heavy alcohol consumption: Diagnostic and treatment implications. American Journal of Psychiatry, 154(6), 846-851.
19. Ishiguro, H., Haruo Shibuya, T., Toru, M., Saito, T., & Arinami, T. (1999a). Association study between high and low activity polymorphism of catechol-O-methyltransferase gene and alcoholism. Psychiatric Genetics, 9(3), 135-138.
20. Ishiguro, H., Saito, T., Akazawa, S., Mitushio, H., Tada, K., Enomoto, M. et al. (1999b). Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population. Alcoholism: Clinical and Experimental Research, 23(7), 1281-1284.
21. Jackson, J. C., Gordon, S. M., Hart, R. P., Hopkins, R. O., & Ely, E. W. (2004). The association between delirium and cognitive decline: A review of the empirical literature. Neuropsychological Review, 14(2), 87-98.
22. Johann, M., Putzhammer, A., Eichhammer, P., & Wodarz, N. (2005). Association of the -141C Del variant of the dopamine D2 receptor (DRD2) with positive family history and suicidality in German alcoholics. American Journal of Medical Genetics B Neuropsychiatric Genetics, 132B(1), 46-49.
23. Juva, K., Verkkoniemi, A., Viramo, P., Polvikoski, T., Kainulainen, K., Kontula, K. et al. (2000a). APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology, 54(2), 412-415.
24. Juva, K., Verkkoniemi, A., Viramo, P., Polvikoski, T., Kainulainen, K., Kontula, K. et al. (2000b). Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over. International Psychogeriatrics, 12(3), 379-387.
25. Kauhanen, J., Hallikainen, T., Tuomainen, T. P., Koulu, M., Karvonen, M. K., Salonen, J. T. et al. (2000). Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcoholism: Clinical and Experimental Research, 24(2), 135-139.
26. Koehnke, M. D., Schick, S., Lutz, U., Willecke, M., Koehnke, A. M., Kolb, W. et al. (2002). Severity of alcohol withdrawal symptoms and the T1128C polymorphism of the neuropeptide Y gene. Journal of Neural Transmission, 109(11), 1423-1429.
27. Kohnke, M. D., Batra, A., Kolb, W., Kohnke, A. M., Lutz, U., Schick, S. et al. (2005). Association of the dopamine transporter gene with alcoholism. Alcohol and Alcoholism, 40(5), 339-342.
28. Kohnke, M. D., Kolb, W., Kohnke, A. M., Lutz, U., Schick, S., & Batra, A. (2006a). DBH*444G/A polymorphism of the dopamine-beta- hydroxylase gene is associated with alcoholism but not with severe alcohol withdrawal symptoms. Journal of Neural Transmission, 113(7), 869-876.
29. Kohnke, M. D., Kolb, W., Lutz, U., Maurer, S., & Batra, A. (2006b). The serotonin transporter promotor polymorphism 5-HTTLPR is not associated with alcoholism or severe forms of alcohol withdrawal in a German sample. Psychiatric Genetics, 16(6), 227-228.
30. Kohnke, M. D., Lutz, U., Kolb, W., Maurer, S., Wiatr, G., & Batra, A. (2006c). Allele distribution of a monoamine oxidase A gene promoter polymorphism in German alcoholics and in subgroups with severe forms of alcohol withdrawal and its influence on plasma homovanillic acid. Psychiatric Genetics, 16(6), 237-238.
31. Kohnke, M. D., Wiatr, G., Kolb, W., Kohnke, A. M., Schick, S., Lutz, U. et al. (2003). Plasma homovanillic acid: A significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. Neuropsychopharmacology, 28(5), 1004-1010.
32. Kohnke, M. D., Zabetian, C. P., Anderson, G. M., Kolb, W., Gaertner, I., Buchkremer, G. et al. (2002). A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function. Biological Psychiatry, 52(12), 1151-1158.
33. Laine, T. P., Ahonen, A., Torniainen, P., Heikkila, J., Pyhtinen, J., Rasanen, P. et al. (1999). Dopamine transporters increase in human brain after alcohol withdrawal. Molecular Psychiatry, 4(2), 189-191, 104-185.
34. Leung, J. M., Sands, L. P., Wang, Y., Poon, A., Kwok, P. Y., Kane, J. P. et al. (2007). Apolipoprotein E e4 allele increases the risk of early postoperative delirium in older patients undergoing noncardiac surgery. Anesthesiology, 107(3), 406-411.
35. Levkoff, S. E., Evans, D. A., Liptzin, B., Cleary, P. D., Lipsitz, L. A., Wetle, T. T. et al. (1992). Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Archives of Internal Medicine, 152(2), 334-340.
36. Limosin, F., Loze, J.-Y., Boni, C., Fedeli, L.-P., Hamon, M., Rouillon, F. et al. (2004). The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neuroscience Letters, 362(2), 91-94.
37. Macdonald, A. J., & Treloar, A. (1996). Delirium and dementia: Are they distinct? Journal of the American Geriatrics Society, 44(8), 1001-1002.
38. Matsushita, S., Kimura, M., Miyakawa, T., Yoshino, A., Murayama, M., Masaki, T. et al. (2004). Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcoholism: Clinical and Experimental Research, 28(11), 1609-1612.
39. Matsushita, S., Yoshino, A., Murayama, M., Kimura, M., Muramatsu, T., & Higuchi, S. (2001). Association study of serotonin transporter gene regulatory region polymorphism and alcoholism. American Journal of Medical Genetetics, 105(5), 446-450.
40. Mayo-Smith, M. F. (1997). Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Journal of the American Medical Association, 278(2), 144-151.
41. McCusker, J., Cole, M., Dendukuri, N., Belzile, E., & Primeau, F. (2001). Delirium in older medical inpatients and subsequent cognitive and functional status: A prospective study. Canadian Medical Association Journal, 165(5), 575-583.
42. Okubo, T., Harada, S., Higuchi, S., & Matsushita, S. (2000). Genetic polymorphism of the CCK gene in patients with alcohol withdrawal symptoms. Alcoholism: Clinical and Experimental Research, 24(4 Suppl.), 2S-4S.
43. Okubo, T., Harada, S., Higuchi, S., & Matsushita, S. (2003). Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms. Alcoholism: Clinical and Experimental Research, 27(8 Suppl.), 68S-71S.
44. Palmstierna, T. (2001). A model for predicting alcohol withdrawal delirium. Psychiatric Services, 52(6), 820-823.
45. Preuss, U. W., Koller, G., Bahlmann, M., Zill, P., Soyka, M., & Bondy, B. (2002). No association between metabotropic glutamate receptors 7 and 8 (mGlur7 and mGlur8) gene polymorphisms and withdrawal seizures and delirium tremens in alcohol-dependent individuals. Alcohol and Alcoholism, 37(2), 174-178.
46. Preuss, U. W., Koller, G., Zill, P., Bondy, B., & Soyka, M. (2003). Alcoholism-related phenotypes and genetic variants of the CB1 receptor. European Archives of Psychiatry and Clinical Neuroscience, 253(6), 275-280.
47. Preuss, U. W., Zill, P., Koller, G., Bondy, B., Hesselbrock, V., & Soyka, M. (2006). Ionotropic glutamate receptor gene GRIK3 SER310ALA functional polymorphism is related to delirium tremens in alcoholics. Pharmacogenomics Journal, 6(1), 34-41.
48. Rommelspacher, H., Raeder, C., Kaulen, P., & Bruning, G. (1992). Adaptive changes of dopamine-D2 receptors in rat brain following ethanol withdrawal: A quantitative autoradiographic investigation. Alcohol, 9(5), 355-362.
49. Rudberg, M. A., Pompei, P., Foreman, M. D., Ross, R. E., & Cassel, C. K. (1997). The natural history of delirium in older hospitalized patients: A syndrome of heterogeneity. Age & Ageing, 26(3), 169-174.
50. Rujescu, D., Soyka, M., Dahmen, N., Preuss, U., Hartmann, A. M., Giegling, I. et al. (2005). GRIN1 locus may modify the susceptibility to seizures during alcohol withdrawal. American Journal of Medical Genetics B Neuropsychiatric Genetics, 133B(1), 85-87.
51. Sander, T., Ball, D., Murray, R., Patel, J., Samochowiec, J., Winterer, G. et al. (1999). Association analysis of sequence variants of GABA(A) alpha6, beta2, and gamma2 gene cluster and alcohol dependence. Alcoholism: Clinical and Experimental Research, 23(3), 427-431.
52. Sander, T., Harms, H., Podschus, J., Finckh, U., Nickel, B., Rolfs, A. et al. (1995). Dopamine D1, D2 and D3 receptor genes in alcohol dependence. Psychiatric Genetics, 5(4), 171-176.
53. Sander, T., Harms, H., Podschus, J., Finckh, U., Nickel, B., Rolfs, A. et al. (1997). Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biological Psychiatry, 41(3), 299-304.
54. Sander, T., Harms, H., Rommelspacher, H., Hoehe, M., & Schmidt, L. G. (1998). Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcohol-withdrawal delirium. Psychiatric Genetics, 8(1), 13-17.
55. Sano, H., Suzuki, Y., Yazaki, R., Tamefusa, K., Ohara, K., Yokoyama, T. et al. (1993). Circadian variation in plasma 5-hydroxyindoleacetic acid level during and after alcohol withdrawal: Phase advances in alcoholic patients compared with normal subjects. Acta Psychiatrica Scandinavia, 87(4), 291-296.
56. Saunders, J., & Janca, A. (2000). Delirium tremens: Its aetiology, natural history and treatment. Current Opinion in Psychiatry, 13, 629-633.
57. Schmidt, L. G., Samochowiec, J., Finckh, U., Fiszer-Piosik, E., Horodnicki, J., Wendel, B. et al. (2002). Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug & Alcohol Dependency, 65(3), 221-224.
58. Schmidt, L. G., & Sander, T. (2000). Genetics of alcohol withdrawal. European Psychiatry, 15(2), 135-139.
59. Shaner, A. (1999). Delusions, superstitious conditioning and chaotic dopamine neurodynamics. Medical Hypotheses, 52(2), 119-123.
60. Shen, R. Y., & Chiodo, L. A. (1993). Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area. Brain Research, 622(1-2), 289-293.
61. Siddiqi, N., House, A. O., & Holmes, J. D. (2006). Occurrence and outcome of delirium in medical in-patients: A systematic literature review. Age & Ageing, 35(4), 350-364.
62. Sobel, E., Louhija, J., Sulkava, R., Davanipour, Z., Kontula, K., Miettinen, H. et al. (1995). Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology, 45(5), 903-907.
63. Spanagel, R., Rosenwasser, A. M., Schumann, G., & Sarkar, D. K. (2005). Alcohol consumption and the body's biological clock. Alcoholism: Clinical and Experimental Research, 29(8), 1550-1557.
64. Tadic, A., Dahmen, N., Szegedi, A., Rujescu, D., Giegling, I., Koller, G. et al. (2005). Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens. European Archives of Psychiatry and Clinical Neuroscience, 255(2), 129-135.
65. Tagarakis, G. I., Tsolaki-Tagaraki, F., Tsolaki, M., Diegeler, A., Tsilimingas, N. B., & Papassotiropoulos, A. (2007a). The role of apolipoprotein E in cognitive decline and delirium after bypass heart operations. American Journal of Alzheimer's Disease and Other Dementias, 22(3), 223-228.
66. Tagarakis, G. I., Tsolaki-Tagaraki, F., Tsolaki, M., Diegeler, A., Kazis, D., Rouska, E. et al. (2007b). The role of SOAT-1 polymorphisms in cognitive decline and delirium after bypass heart surgery. Clinical Research in Cardiology, 96, 600-3.
67. Tiihonen, J., Hallikainen, T., Lachman, H., Saito, T., Volavka, J., Kauhanen, J. et al. (1999). Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Molecular Psychiatry, 4, 286-289.
68. Tsai, G., & Coyle, J. T. (1998). The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annual Review of Medicine, 49, 173-184.
69. Tsai, G., Gastfriend, D. R., & Coyle, J. T. (1995). The glutamatergic basis of human alcoholism. American Journal of Psychiatry, 152(3), 332-340.
70. van Munster, B. C., Korevaar, J. C., de Rooij, S. E., Levi, M., & Zwinderman, A. H. (2007a). Genetic polymorphisms related to delirium tremens: A systematic review. Alcoholism: Clinical and Experimental Research, 31(2), 177-184.
71. van Munster, B. C., Korevaar, J. C., de Rooij, S. E., Levi, M., & Zwinderman, A. H. (2007b). The association between delirium and the apolipoprotein E epsilon4 allele in the elderly. Psychiatric Genetics, 17(5), 261-266.
72. Wernicke, C., Smolka, M., Gallinat, J., Winterer, G., Schmidt, L. G., & Rommelspacher, H. (2002). Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population. Neuroscience Letters, 333(1), 45-48.
73. Wodarz, N., Bobbe, G., Eichhammer, P., Weijers, H. G., Wiesbeck, G. A., & Johann, M. (2003). The candidate gene approach in alcoholism: Are there gender-specific differences? Archives of Women's Mental Health, 6(4), 225-230.
74. Wood, P. L., & Altar, C. A. (1988). Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: Utility of 3-methoxytyramine measurements. Pharmacological Review, 40(3), 163-187.
75. WHO (World Health Organisation) (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.